Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/24168
Tipo de Documento: Artigo
Título: Amyotrophic lateral sclerosis: a focus on disease progression
Autor(es): Calvo, Ana Cristina
Manzano, Raquel
Mendonça, Deise Maria Furtado de
Muñoz, María J.
Zaragoza, Pilar
Osta, Rosario
Data do documento: 2014
Resumo: Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerative disease in which motorneuron death is induced, a wide range of biomarkers have been selected to identify therapeutic targets. ALS shares altered molecular pathways with other neurodegenerative diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s diseases. However,the molecular targets that directly influence its aggressive nature remain unknown. What is the first link in the neurodegenerativechain of ALS that makes this disease so peculiar? In this review, we will discuss the progression of the disease from the viewpointof the potential biomarkers described to date in human and animal model samples. Finally, we will consider potential therapeuticstrategies for ALS treatment and future, innovative perspectives.
Palavras-chave: Amyotrophic lateral sclerosis
Neurodegenerative diseases
Disease progression
Therapeutic strategies
ISSN: 2314-6141
Parte de : BioMed Research International
Idioma: eng
Instituição/Editora: Hindawi Publishing Corporation
Citação: CALVO, A. C. et al. Amyotrophic lateral sclerosis: a focus on disease progression. BioMed Research International, New York, n. 1, 2014. Disponível em: https://onlinelibrary.wiley.com/doi/epdf/10.1155/2014/925101. Acesso em: 9 jan. 2026.
Licença: Creative Commons Atribuição 3.0 Não Adaptada (CC BY 3.0)
URI: https://ri.ufs.br/jspui/handle/riufs/24168
Aparece nas coleções:DBCI - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
AmyotrophicLateralSclerosisDiseaseProgression.pdf376,06 kBAdobe PDFThumbnail
Visualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.